The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 31, 2026 for Ravi Agrawal, trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ravi Agrawal, trustee of Ravi Agrawal Trust (promoter holding 13% stake in Ajanta Pharma), disclosed creation and release of pledges on equity shares. On March 25, 2026, he released pledges on 7,95,000 shares (0.63%) held across Bajaj Finance, Aditya Birla Capital, RBL Bank and HSBC InvestDirect. Subsequently on March 27, 2026, he created fresh pledges on 9,18,000 shares (0.73%) with Tata Capital, RBL Bank, Bajaj Finance and Aditya Birla Capital. The re-financing activity resulted in a net increase of 1,23,000 pledged shares. Post-event, 6,063,920 shares (4.85%) remain encumbered under the trust.
The pledge activity represents routine re-financing of promoter financing arrangements with no significant change to the encumbrance level (4.85%), and does not indicate any immediate concern for shareholders.